<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="other">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
      <journal-title>Febs Letters</journal-title>
      <issn pub-type="ppub">0014-5793</issn>
      <issn pub-type="epub">1873-3468</issn>
      <publisher>
        <publisher-name>Elsevier Science B.V</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2734061</article-id>
      <article-id pub-id-type="pmid">19433089</article-id>
      <article-id pub-id-type="publisher-id">FEBS33262</article-id>
      <article-id pub-id-type="doi">10.1016/j.febslet.2009.05.005</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Minireview</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Glimpses of the molecular mechanisms of β<sub>2</sub>-microglobulin fibril formation in vitro: Aggregation on a complex energy landscape</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Platt</surname>
            <given-names>Geoffrey W.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Radford</surname>
            <given-names>Sheena E.</given-names>
          </name>
          <email>S.E.Radford@leeds.ac.uk</email>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff>
        <addr-line>Astbury Centre for Structural Molecular Biology and Institute of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Fax: +44 113 343 7486. <email>S.E.Radford@leeds.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>20</day>
        <month>8</month>
        <year>2009</year>
      </pub-date>
      <volume>583</volume>
      <issue>16</issue>
      <fpage>2623</fpage>
      <lpage>2629</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>3</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>1</day>
          <month>5</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>5</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2009 Elsevier B.V..</copyright-statement>
        <copyright-year>2009</copyright-year>
        <copyright-holder>Federation of European Biochemical Societies</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <title>Abstract</title>
        <p>β<sub>2</sub>-microglobulin (β<sub>2</sub>m) is a 99-residue protein that aggregates to form amyloid fibrils in dialysis-related amyloidosis. The protein provides a powerful model for exploration of the structural molecular mechanisms of fibril formation from a full-length protein in vitro. Fibrils have been assembled from β<sub>2</sub>m under both low pH conditions, where the precursor is disordered, and at neutral pH where the protein is initially natively folded. Here we discuss the roles of sequence and structure in amyloid formation, the current understanding of the structural mechanisms of the early stages of aggregation of β<sub>2</sub>m at both low and neutral pH, and the common and distinct features of these assembly pathways.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>DRA, dialysis-related amyloidosis</kwd>
        <kwd>NMR, nuclear magnetic resonance</kwd>
        <kwd>SEC, size exclusion chromatography</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>β<sub>2</sub>-microglobulin</kwd>
        <kwd>Amyloid fibrils</kwd>
        <kwd>Mechanisms</kwd>
        <kwd>Structure</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>The aggregation of proteins into amyloid fibrils has been studied in detail for more than 50 years, yet elucidation of the exact structural mechanisms of this process still provides a considerable challenge <xref rid="bib1" ref-type="bibr">[1]</xref>. The heterogeneous nature of the protein aggregation landscape contributes to the complexity of this problem. Indeed, even at the earliest stage of this process the monomeric precursors of amyloid formation can be found as a complex mixture that can include natively folded, partially folded and highly unfolded protein species, any one of which could initiate the aggregation process. Furthermore, since the inter- and intra-molecular interactions that are involved in aggregation and protein folding are similar, much work remains to improve our understanding of the competition between these events, especially at the initial stages of amyloid formation (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A) <xref rid="bib2" ref-type="bibr">[2]</xref>. Moreover, multiple practical challenges exist as the formation of fibrils is stochastic and many of the species populated en route to the fibril product are unstable and only transiently formed. Understanding the biophysical nature of amyloid formation, however, is an important goal, not only because a number of diseases involve the deposition of amyloid fibrils <xref rid="bib3" ref-type="bibr">[3]</xref>, but also because the ability to form amyloid is known to be a fundamental property of all polypeptide chains under the appropriate conditions, independent of sequence <xref rid="bib4" ref-type="bibr">[4]</xref>. However, the manner in which the generic cross-β structure of amyloid is accommodated by the differing sequences of proteins within their fibrillar architecture is not yet understood.</p>
      <p>To comprehend the process of amyloid fibril formation in atomistic detail much work has been performed on a range of proteins in vitro. Here, we review some of the techniques employed and the results obtained in the study of the structural and molecular mechanisms of fibril formation of the protein β<sub>2</sub>-microglobulin (β<sub>2</sub>m). This protein folds natively into a β-sandwich fold consisting of two β-sheets, one containing four strands (ABED) and the other three (CFG) (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B) <xref rid="bib5" ref-type="bibr">[5]</xref>. A disulphide bond between two cysteines (residues 25 and 80) covalently links these sheets <xref rid="bib5" ref-type="bibr">[5]</xref>. Intact wild-type β<sub>2</sub>m is the major component of amyloid fibrils deposited in the joints of patients on long-term haemodialysis, in a condition known as dialysis-related amyloidosis (DRA). In vivo, β<sub>2</sub>m is the non-covalently attached light chain of the human major histocompatibility complex 1 (MHC1) <xref rid="bib5" ref-type="bibr">[5]</xref>. Naturally, β<sub>2</sub>m is shed into the serum and degraded by the kidneys, maintaining the serum β<sub>2</sub>m concentrations at 0.09–0.17 μM in healthy individuals <xref rid="bib6" ref-type="bibr">[6]</xref>. However, in patients with renal failure the haemodialysis membrane is unable to remove β<sub>2</sub>m, resulting in increases in the serum concentration by up to 60-fold <xref rid="bib7" ref-type="bibr">[7]</xref>. This rise in concentration alone is deemed not to be sufficient for fibril formation <xref rid="bib8" ref-type="bibr">[8]</xref>. Thus other, as yet unknown, contributing factors lead to deposition of the full-length β<sub>2</sub>m as amyloid fibres in the synovium of joints.</p>
      <p>Here we consider the current state of research into the mechanism of β<sub>2</sub>m fibril formation in vitro. We discuss the fibril formation pathways under different conditions, how they may be related to one another and to the mechanism occurring in vivo; and how the amyloid forming potential of β<sub>2</sub>m is modulated by sequence and structural changes.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Sequence versus structural determinants of fibril formation</title>
      <p>Studies using prediction algorithms and peptide models have indicated that ∼60% of the sequence of β<sub>2</sub>m is highly amyloidogenic (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C) <xref rid="bib9 bib10 bib11 bib12 bib13 bib14 bib15" ref-type="bibr">[9–15]</xref>. However, the innate amyloid forming potential of the polypeptide sequence of β<sub>2</sub>m is modulated by structure, as the natively folded protein is impervious to aggregation <xref rid="bib8 bib16" ref-type="bibr">[8,16]</xref>. At least a partial unfolding event must therefore take place in vivo to allow exposure of one or more aggregation-prone region(s) of the sequence to initiate amyloid formation. To study fibril formation of β<sub>2</sub>m in vitro, many destabilising conditions have been applied, by adding co-solvents, detergents or denaturants at neutral pH or by reducing the pH to drive the aggregation process on a biophysically feasible timescale <xref rid="bib17" ref-type="bibr">[17]</xref>.</p>
      <p>At low pH (&lt;pH 3.0), low ionic strength (⩽50 mM) and encouraged by agitation, β<sub>2</sub>m spontaneously aggregates in vitro to form fibrils with all of the hallmarks of amyloid <xref rid="bib16" ref-type="bibr">[16]</xref>. Kinetic analyses of fibril growth coupled with a mutational screen have indicated that a single region approximately 10 residues in length (∼60–70) is important for determining the rate of fibril nucleation and elongation of the full-length protein under these conditions (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C) <xref rid="bib18 bib19" ref-type="bibr">[18,19]</xref>. This region of the sequence is enriched in aromatic residues and is predicted to be highly aggregation-prone by amyloid algorithms <xref rid="bib9" ref-type="bibr">[9]</xref>. Other studies of the full-length β<sub>2</sub>m sequence at low pH have indicated that its ability to form amyloid is related to the stability of the fibrils and that introduction of the β-sheet breaking amino acid, Pro, in place of certain residues, especially Leu23, His51 or Val82, causes a reduction in fibril elongation kinetics <xref rid="bib20" ref-type="bibr">[20]</xref>. Comparison of the effects of sequence alteration on the fibril growth kinetics of the intact, oxidised protein at low pH with the results of peptide studies is striking. While fragments corresponding to three regions (residues 20–40, 60–70 and ∼80–99) all form amyloid in isolation <xref rid="bib10 bib11 bib12 bib13 bib14 bib15 bib19" ref-type="bibr">[10–15,19]</xref>, in the context of the full-length protein chain mutation of residues in only one region (∼60–70) alters the fibril formation kinetics (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C) <xref rid="bib18 bib19" ref-type="bibr">[18,19]</xref>. One explanation of this observation is that structure in the initial denatured state may modulate the amyloid potential of the polypeptide chain, even when the initial amyloid precursor is highly unfolded (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A) <xref rid="bib19" ref-type="bibr">[19]</xref>. Indeed, nuclear magnetic resonance (NMR) analysis indicates that the acid unfolded state of β<sub>2</sub>m contains non-native residual structure, stabilised by the disulphide bond, which involves the clustering of hydrophobic residues in two regions (29–51 and 58–79) <xref rid="bib21" ref-type="bibr">[21]</xref>. Therefore, even in this highly dynamic species the amyloid forming potential of the sequence may be modulated by structure, with the result that only one short stretch of residues (∼60–70) determines the aggregation potential of the entire 99-residue sequence. Examination of the crystal structure of β<sub>2</sub>m in the MHC class I complex illustrates why the protein may contain such a highly aggregation-prone sequence. Aromatic residues including Phe56, Trp60, Phe62 and Tyr63 (as well as the hydrophobic residue Leu65), which all lie in the aggregation-determining sequence, make important contacts with the MHC I heavy chain (<xref rid="fig1" ref-type="fig">Fig. 1</xref>D) <xref rid="bib5" ref-type="bibr">[5]</xref>. Indeed, mutation of Trp60 to Gly results in a weakened interaction with the heavy chain, and a more stable native state that is less aggregation-prone <xref rid="bib22" ref-type="bibr">[22]</xref>. This part of the sequence thus appears to have evolved for functional reasons (maintenance of the immune system) without consideration of the consequences for aggregation.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Structural mechanisms of the early events in β<sub>2</sub>m aggregation at pH 2.5</title>
      <p>At low pH β<sub>2</sub>m fibril formation proceeds rapidly from a highly dynamic state with lag-dependent kinetics <xref rid="bib16 bib23" ref-type="bibr">[16,23]</xref>, indicative of a nucleation-dependent mechanism. Mass spectrometry data indicates that small oligomers including dimers, trimers and tetramers (but no larger assemblies) are observed to form during the lag time of the aggregation process (<xref rid="fig2" ref-type="fig">Fig. 2</xref>) <xref rid="bib24" ref-type="bibr">[24]</xref>. That higher order assemblies are not detected implies that larger oligomers may rapidly aggregate into fibrils, or such species may not be detectable by mass spectrometry. Numerical modelling studies of the kinetics of fibril formation at different protein concentrations, which included over 20 different possible assembly mechanisms, suggest that the initial molecular recognition events involve the assembly of monomers leading to the formation of a high-energy structural nucleus consisting of six β<sub>2</sub>m polypeptide chains. Elongation then proceeds rapidly to form amyloid-like fibres by monomer addition <xref rid="bib23" ref-type="bibr">[23]</xref>. Structural detail of the observed oligomers is sparse but little ordered secondary structure is observed by FTIR <xref rid="bib25" ref-type="bibr">[25]</xref>, and these species do not bind the antibody A11 (unpublished data), which has commonly been used to detect toxic oligomers that form en route to amyloid fibrils from many different proteins <xref rid="bib26" ref-type="bibr">[26]</xref>. Presently, the structural role of the aromatic-rich region involving residues ∼60–70 in these early assembly intermediates is unknown <xref rid="bib18 bib19" ref-type="bibr">[18,19]</xref>, although previous studies have noted the importance of aromatic stacking interactions in amyloid formation <xref rid="bib27" ref-type="bibr">[27]</xref>.</p>
      <p>Information towards understanding the elongation of β<sub>2</sub>m fibrils was gained in a study at pH 2.5 by total internal reflection fluorescence microscopy, which indicated that this process is unidirectional when the fibrils are fixed on a glass surface, implying a polarised aggregation mechanism <xref rid="bib28" ref-type="bibr">[28]</xref>. Interestingly, this method also indicated that fibrils elongate at a range of rates suggesting a variety of structural differences in the long-straight amyloid structures formed at pH 2.5 and highlighting the complexities of studying amyloid fibril formation whereby different fibril structures co-exist at equilibrium that are difficult to discern without recourse to detailed structural analysis.</p>
    </sec>
    <sec>
      <label>4</label>
      <title>A structural trigger at neutral pH?</title>
      <p>To mimic conditions that are more physiologically relevant, studies in vitro have adopted a number of methods to drive amyloid formation of β<sub>2</sub>m at neutral pH, since the protein is initially natively folded at pH 7. Biological components, including glycosaminoglycans, proteoglycans, collagen and Cu<sup>2+</sup> (the latter in the presence of 1 M urea) have all been used to promote, or induce, fibril formation at neutral pH in vitro <xref rid="bib8 bib29 bib30 bib31" ref-type="bibr">[8,29–31]</xref>. In addition, co-solvents such as TFE or SDS, alteration of the physical environment by ultrasonication, elevated temperature or stirring at high concentrations of salt induce fibril formation from wild-type β<sub>2</sub>m at, or close to, neutral pH <xref rid="bib32 bib33 bib34 bib35" ref-type="bibr">[32–35]</xref>. Alterations of the protein sequence have also been used to stimulate the formation of fibrils at neutral pH. Specifically, truncation of six residues from the N-terminal region (ΔN6), as well as mutation in this region (P5G) or in the B/C or D/E loops (P32A, P32G, D59P) of the protein all enhance its ability to form amyloid in vitro (<xref rid="fig3" ref-type="fig">Fig. 3</xref>), while substitutions elsewhere in the protein have little effect <xref rid="bib31 bib36 bib37 bib38" ref-type="bibr">[31,36–38]</xref>. These studies have the common feature that they encourage partial unfolding of β<sub>2</sub>m, allowing the aggregation-prone regions of the polypeptide sequence to be exposed and to participate in intermolecular interactions.</p>
      <p>The β<sub>2</sub>m variants, P32G and P32V, have been used to show that wild-type β<sub>2</sub>m populates a native-like folding intermediate (called I<sub>T</sub>) en route to the native state that contains a non-native <italic>trans</italic> Pro32 bond <xref rid="bib37 bib39 bib40" ref-type="bibr">[37,39,40]</xref>. Increased population of this intermediate in the variant P32G was shown to be concomitant with increased ability of the protein to elongate β<sub>2</sub>m fibril seeds <xref rid="bib37" ref-type="bibr">[37]</xref>. Interestingly, it may be that a specific <italic>trans</italic> Pro32 residue is important for β<sub>2</sub>m to nucleate amyloid fibrils at neutral pH, as both P32G and P32V β<sub>2</sub>m which form <italic>trans</italic> Gly32 or Val32 cannot form amyloid-like fibrils spontaneously, although P32G can elongate stabilised seeds more efficiently than wild-type β<sub>2</sub>m under the conditions employed <xref rid="bib37 bib40" ref-type="bibr">[37,40]</xref>. Other variants, such as P5G and ΔN6, also affect isomerisation of the Pro32 peptide bond, promoting population of I<sub>T</sub> and enabling fibril nucleation at pH 7.0 <xref rid="bib36" ref-type="bibr">[36]</xref>. In separate studies β<sub>2</sub>m has been shown to form oligomers and fibrils at neutral pH by addition of Cu<sup>2+</sup> and 1 M urea <xref rid="bib8 bib31" ref-type="bibr">[8,31]</xref>. This induces the formation of a non-native species, called M<sup>∗</sup>, that appears identical to I<sub>T</sub> by size exclusion chromatography (SEC) <xref rid="bib36" ref-type="bibr">[36]</xref>. Coordination of the metal ion promotes peptide bond isomerisation at Pro32 <xref rid="bib31" ref-type="bibr">[31]</xref>, and the subsequent rapid formation of oligomers as judged by SEC, providing further supporting evidence that the isomerisation of Pro32 is a key initial step on the pathway to fibrils <xref rid="bib8 bib31 bib36" ref-type="bibr">[8,31,36]</xref>.</p>
      <p>Structural studies of the trapped folding intermediate, I<sub>T</sub> (or M<sup>∗</sup>), have provided molecular insights into the possible aggregation mechanisms of β<sub>2</sub>m at neutral pH. Burst-phase amplitudes from real-time NMR studies of β<sub>2</sub>m folding indicate that residues distal to Pro32 maintain native-like structure in the intermediate, while regions proximal to Pro32 in the B/C loop are disordered until <italic>trans</italic> to <italic>cis</italic> isomerisation of the Pro32 peptide bond takes place <xref rid="bib40" ref-type="bibr">[40]</xref>. Consistent with this, studies of P32G by NMR have shown that residues in the B/C loop, the adjacent F/G loop and the edge β-strands A and D are altered in the intermediate I<sub>T</sub> (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). Crystallographic data for a mutant, P32A, that populates the native-like M<sup>∗</sup> state at neutral pH, shows that this conformer results in substantial reorganisation of aromatic side-chains that are present in the core of the native protein <xref rid="bib31" ref-type="bibr">[31]</xref>. In this structure, a number of aromatic and hydrophobic residues are displaced including Phe30, Phe56, Trp60, Phe62, Tyr63 and Leu54. These rearrangements present a strip of exposed hydrophobic residues on the protein surface, providing a possible avenue for protein aggregation. Furthermore, the structural changes lead to alterations in the organisation of residues 52–56, including abolition of the β-bulge that is present in the native β-strand D and is a deterrent to edge strand aggregation (<xref rid="fig3" ref-type="fig">Fig. 3</xref>) <xref rid="bib41" ref-type="bibr">[41]</xref>. This species crystallises as a dimer underlining its potential to form intermolecular interactions <xref rid="bib31" ref-type="bibr">[31]</xref>.</p>
      <p>Other regions of the β<sub>2</sub>m sequence have been proposed to modulate fibril formation at neutral pH and do not involve isomerisation of the Pro32 peptide bond. Substitution of Trp60 in the D/E loop with Gly increases the stability of the native state and reduces the ability of the protein to aggregate at neutral pH in the presence of TFE <xref rid="bib22" ref-type="bibr">[22]</xref>. Removal of this large, hydrophobic side chain will not only reduce the inherent aggregation potential of the protein chain but, by decreasing strain in the loop region adjacent to the aromatic-rich, amyloidogenic sequence of β-strand E <xref rid="bib18" ref-type="bibr">[18]</xref>, the native state is stabilised, hence further reducing its ability to aggregate (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). Indeed, a D59P variant that increases strain in the D/E loop region and reduces protein stability shows an increased potential to form fibrils (<xref rid="fig3" ref-type="fig">Fig. 3</xref>) <xref rid="bib38" ref-type="bibr">[38]</xref>.</p>
    </sec>
    <sec>
      <label>5</label>
      <title>A common fibrillar architecture is formed from diverse precursors</title>
      <p>Akin to a protein folding landscape, aggregation into amyloid may be achieved via a number of routes. In aqueous conditions at pH 2.5 and 7.0 amyloid-like fibrils are formed from β<sub>2</sub>m that show a long-straight, left-hand twisted and unbranched morphology when observed by EM and AFM (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A) <xref rid="bib42" ref-type="bibr">[42]</xref>. Fibrils formed at both pH values bind the amyloid-specific dyes ThT and Congo Red; display characteristic cross-β structure as evidenced by X-ray fibre diffraction (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A) and exhibit an identical β-sheet content when studied by FTIR <xref rid="bib42" ref-type="bibr">[42]</xref>. However, some differences between the fibrils must exist as those formed at pH 2.5 depolymerise at pH 7 unless stabilised by co-factors such as glycosaminoglycans <xref rid="bib29" ref-type="bibr">[29]</xref>. Comparison of the fibrils formed at pH 2.5 and 7.0 by FTIR, a technique that is highly sensitive to the length and twist of β-strands, suggests that the polypeptide chain is ordered in a similar parallel fashion in both fibril types <xref rid="bib25 bib42" ref-type="bibr">[25,42]</xref>. These structural similarities are shared by ex vivo fibrils obtained from DRA patients, implying that study of the processes that lead to fibrils in vitro under aqueous conditions, even at low pH, may provide relevant information about the formation of fibrils in disease. These findings beg the question of how similar the assembly pathways are and whether these separate pathways converge to form a common fibrillar product (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B). Interestingly, however, the fibrils produced in the presence of SDS or TFE show distinct morphological properties, compared with those formed in the absence of these additives at neutral pH, suggesting that alternative conformations of the fibres (polymorphs) can be formed by fine tuning of the solution conditions <xref rid="bib32 bib43" ref-type="bibr">[32,43]</xref>.</p>
    </sec>
    <sec>
      <label>6</label>
      <title>Progress towards a unifying mechanism of β<sub>2</sub>m fibril formation</title>
      <p>One of the most striking observations of the β<sub>2</sub>m assembly pathways is that the fibrils formed commencing from a highly denatured state or a native-like precursor are apparently indistinguishable, suggesting that their assembly pathways must converge to a similar fibrillar product. This could occur by unfolding of native β<sub>2</sub>m to allow reorganisation of the protein structure; or by refolding of the highly dynamic polypeptide chain at pH 2.5 to a more structurally ordered intermediate species (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B). The kinetics of fibril formation suggest that the acid unfolded precursor can readily access a critical aggregation-prone species, since amyloid formation proceeds rapidly (within hours) under these conditions <xref rid="bib18 bib23" ref-type="bibr">[18,23]</xref>. By contrast, at pH 7, even in the presence of fibril seeds, fibril formation takes weeks <xref rid="bib36" ref-type="bibr">[36]</xref>. Similarities between the assembly mechanisms are supported by the proposal that aromatic interactions are crucial for driving fibrillogenesis under both sets of conditions <xref rid="bib12 bib18 bib19 bib31" ref-type="bibr">[12,18,19,31]</xref>. Indeed, the dimeric structure of M<sup>∗</sup> <xref rid="bib31" ref-type="bibr">[31]</xref>, indicates that interactions between specific and structurally organised hydrophobic and aromatic residues may lead to fibrillation. Moreover, removal of the β-bulge from β-strand D, as observed for many of the fibril-forming variants of β<sub>2</sub>m formed at neutral pH (<xref rid="fig3" ref-type="fig">Fig. 3</xref>), could provide a site for productive intermolecular edge strand interactions. Interestingly, a rare conformer of wild-type β<sub>2</sub>m with a straightened β-strand D has been observed in crystallography studies (<xref rid="fig3" ref-type="fig">Fig. 3</xref>) <xref rid="bib44" ref-type="bibr">[44]</xref>. Whilst this wild-type conformer has different sidechain organisation to that observed for the variants capable of forming fibrils at neutral pH (P32A, D59P) it provides evidence (alongside that of other variants, such as W60G) <xref rid="bib22 bib43" ref-type="bibr">[22,43]</xref> that this edge strand straightening is not sufficient to promote fibril growth. Another convergent feature arises from a suggested model for the fibrils formed at neutral pH that contains a highly charged surface <xref rid="bib31" ref-type="bibr">[31]</xref>, which could be neutralised at low pH, perhaps allowing for a convergence of the mechanisms of assembly at acidic and neutral pH and explaining why the kinetics of fibril formation are much more rapid under acidic conditions. An additional common characteristic is that many variants capable of fibril formation at neutral pH have the effect of destabilising the N-terminal region of the protein <xref rid="bib31 bib37 bib40" ref-type="bibr">[31,37,40]</xref>, which is also highly unfolded in the structural ensembles formed at low pH <xref rid="bib21" ref-type="bibr">[21]</xref>. The disruption of this region has been proposed as key to amyloid formation <xref rid="bib45" ref-type="bibr">[45]</xref>. Indeed, the double variant, P32G/I7A that combines a <italic>trans</italic> peptide bond at Pro32 with destabilisation of the N-terminal region forms fibrils spontaneously at neutral pH <xref rid="bib42" ref-type="bibr">[42]</xref>. The role of <italic>trans</italic> Pro32 in fibril formation at low pH is currently unknown, although ∼80% of the molecules would be expected to contain the <italic>trans</italic> conformation in the acid denatured state <xref rid="bib46" ref-type="bibr">[46]</xref>. Moreover, the observation that the rate of fibril formation of P32G is similar to that of wild-type β<sub>2</sub>m when studied at pH 2.5 is suggestive of a common <italic>trans</italic> amyloid precursor <xref rid="bib19" ref-type="bibr">[19]</xref>.</p>
      <p>The possibility that partial or global unfolding of the initially folded monomer of β<sub>2</sub>m is required for fibrillogenesis at neutral pH is supported by data from a variant of β<sub>2</sub>m that is cleaved at Lys58 (ΔK58), adjacent to the aromatic-rich, aggregation-prone region (∼60–70), and retains a native fold in vitro <xref rid="bib47" ref-type="bibr">[47]</xref>. This variant is fibrillation-prone under conditions similar to those found in vivo (&lt;pH 6.8), where it more frequently populates a highly unprotected state <xref rid="bib48" ref-type="bibr">[48]</xref>. The aggregation-competent species formed in these studies must, however, contain some specific structural attributes as simply creating a variant of β<sub>2</sub>m that is highly unstable and frequently visits an unfolded state (such as V37A) does not engender amyloidogenicity alone <xref rid="bib49" ref-type="bibr">[49]</xref>.</p>
    </sec>
    <sec>
      <label>7</label>
      <title>Summary and outlook</title>
      <p>Studies of the molecular mechanisms of β<sub>2</sub>m aggregation both under denaturing and native conditions have provided important new insights into the structural changes associated with fibril formation for this protein that may have relevance for understanding amyloid in general. The sequence of β<sub>2</sub>m has a high amyloid forming potential as inferred from aggregation prediction algorithms and peptide studies <xref rid="bib9 bib10 bib11 bib12 bib13 bib14 bib15" ref-type="bibr">[9–15]</xref>. However, work on the full-length protein indicates that the aggregation potential of this sequence is highly modulated by structure, not just in the native state, wherein the aggregation-prone regions are completely sequestered in the native core, but also in the highly dynamic acid unfolded state. Thus, whilst peptide fragment studies are of great utility in answering fundamental questions regarding amyloid formation, their study in context of full-length proteins can be misleading.</p>
      <p>The fact that many different proteins with unrelated sequences and native folds can all form amyloid-like fibrils with nucleation-dependent kinetics implies the possibility of a common mechanism. The finding that β<sub>2</sub>m can form similar long-straight amyloid-like fibrils commencing from two very different structural states reinforces the view of a generic assembly mechanism. Under each set of conditions similar hydrophobic and aromatic regions of the sequence appear to be key to the aggregation mechanism. While reducing the stability of the native fold and increasing global or subglobal unfolding events is important in initiating amyloid formation, some structural preference, for instance the presence of a non-native <italic>trans</italic> Pro32, is clearly linked to the ability to aggregate. Even in the acid unfolded state it appears that specifically structured species presenting aggregation-prone regions are required for amyloid formation, whilst other transiently structured regions may modulate aggregation by sequestering sequences with high amyloid forming potential.</p>
      <p>It is currently unclear whether the same oligomeric species are populated during assembly at acidic and at neutral pH and future endeavours will need to focus on the structural properties of the oligomers that form as aggregation proceeds. Such studies may provide clues as to how fibrillation can be impeded therapeutically and how fibril formation proceeds mechanistically. Indeed, whilst oligomers are commonly observed during fibril formation, there is as yet no definitive proof that such species are on pathway to the fibrillar form. Furthermore, atomistic insights into the structure of β<sub>2</sub>m amyloid fibrils will be required to provide unequivocal evidence for the convergence of the assembly pathways at pH 2.5 and 7.0 and to provide detailed information as to whether the protein is completely refolded in the fibril structure or retains remnants of its native fold. Towards this goal recent cryo-EM studies have shown a remarkably complex architecture for the fibrils formed from β<sub>2</sub>m at pH 2.5 <xref rid="bib51" ref-type="bibr">[51]</xref>. Ultimately, as the studies on β<sub>2</sub>m have helped to confirm, the amyloid-forming potential of a protein is clearly a function of how structure modulates the intrinsic β-aggregation propensity of the amino acid sequence, not just for the natively folded protein but also for proteins that aggregate from highly unfolded initial precursor states.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank past and current members of the Radford group for many helpful discussions. We would particular like to thank Katy Routledge, Thomas Jahn, Louise Serpell, Andrew Smith and Alison Ashcroft for use of their data in the figures. We also acknowledge with thanks Michele Vendruscolo and Steve Homans for their insightful comments. G.W.P. is funded by the Wellcome Trust (Grant Numbers 075675 and 062164).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipe</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Review: history of the amyloid fibril</article-title>
          <source>J. Struct. Biol.</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>88</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">10940217</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tartaglia</surname>
              <given-names>G.G.</given-names>
            </name>
            <name>
              <surname>Pawar</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Campioni</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Chiti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vendruscolo</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Prediction of aggregation-prone regions in structured proteins</article-title>
          <source>J. Mol. Biol.</source>
          <year>2008</year>
          <volume>380</volume>
          <fpage>425</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">18514226</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westermark</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A primer of amyloid nomenclature</article-title>
          <source>Amyloid</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>179</fpage>
          <lpage>183</lpage>
          <pub-id pub-id-type="pmid">17701465</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobson</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Protein folding and misfolding</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>884</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="pmid">14685248</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saper</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Bjorkman</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Wiley</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Refined structure of the human histocompatibility antigen HLA-A2 at 2.6Å resolution</article-title>
          <source>J. Mol. Biol.</source>
          <year>1991</year>
          <volume>219</volume>
          <fpage>277</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="pmid">2038058</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niwa</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>β2-microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products</article-title>
          <source>Nephron</source>
          <year>1997</year>
          <volume>76</volume>
          <fpage>373</fpage>
          <lpage>391</lpage>
          <pub-id pub-id-type="pmid">9274834</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gejyo</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>1985</year>
          <volume>129</volume>
          <fpage>701</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">3893430</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eakin</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Miranker</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>From chance to frequent encounters: origins of β2-microglobulin fibrillogenesis</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2005</year>
          <volume>1753</volume>
          <fpage>92</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="pmid">16226064</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pawar</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>DuBay</surname>
              <given-names>K.F.</given-names>
            </name>
            <name>
              <surname>Zurdo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chiti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vendruscolo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dobson</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Prediction of “aggregation-prone” and “aggregation-susceptible” regions in proteins associated with neurodegenerative diseases</article-title>
          <source>J. Mol. Biol.</source>
          <year>2005</year>
          <volume>350</volume>
          <fpage>379</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">15925383</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kozhukh</surname>
              <given-names>G.V.</given-names>
            </name>
            <name>
              <surname>Hagihara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kawakami</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Investigation of a peptide responsible for amyloid fibril formation of β2-microglobulin by Achromobacter protease I</article-title>
          <source>J. Biol. Chem.</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>1310</fpage>
          <lpage>1315</lpage>
          <pub-id pub-id-type="pmid">11687582</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hasegawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ohhashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Tsutsumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gejyo</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Amyloidogenic synthetic peptides of β2-microglobulin – a role of the disulfide bond</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2003</year>
          <volume>304</volume>
          <fpage>101</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="pmid">12705891</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kad</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-forming peptides from β2-microglobulin – insights into the mechanism of fibril formation in vitro</article-title>
          <source>J. Mol. Biol.</source>
          <year>2003</year>
          <volume>325</volume>
          <fpage>249</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">12488093</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivanova</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Gingery</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Whitson</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Eisenberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Role of the C-terminal 28 residues of β2-microglobulin in amyloid fibril formation</article-title>
          <source>Biochemistry</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>13536</fpage>
          <lpage>13540</lpage>
          <pub-id pub-id-type="pmid">14622000</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivanova</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Sawaya</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Gingery</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Attinger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Eisenberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>An amyloid-forming segment of β2-microglobulin suggests a molecular model for the fibril</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>10584</fpage>
          <lpage>10589</lpage>
          <pub-id pub-id-type="pmid">15249659</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivanova</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Eisenberg</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>A systematic screen of β2-microglobulin and insulin for amyloid-like segments</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>4079</fpage>
          <lpage>4082</lpage>
          <pub-id pub-id-type="pmid">16537488</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>[16]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kad</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>β2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro</article-title>
          <source>J. Mol. Biol.</source>
          <year>2001</year>
          <volume>313</volume>
          <fpage>559</fpage>
          <lpage>571</lpage>
          <pub-id pub-id-type="pmid">11676539</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>[17]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Gosal</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Platt</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Towards an understanding of the structural molecular mechanism of β2-microglobulin amyloid formation in vitro</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2005</year>
          <volume>1753</volume>
          <fpage>51</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">16099226</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>[18]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Platt</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Routledge</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Homans</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Fibril growth kinetics reveal a region of β2-microglobulin important for nucleation and elongation of aggregation</article-title>
          <source>J. Mol. Biol.</source>
          <year>2008</year>
          <volume>378</volume>
          <fpage>251</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">18342332</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <label>[19]</label>
        <citation citation-type="other">Routledge, K.E., Tartaglia, G.G., Platt, G.W., Vendruscolo, M. and Radford, S.E. Competition between intra-molecular and inter-molecular interactions in an amyloid forming protein. J. Mol. Biol., in press.</citation>
      </ref>
      <ref id="bib20">
        <label>[20]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiba</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hagihara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Higurashi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Amyloid fibril formation in the context of full-length protein – effects of proline mutations on the amyloid fibril formation of β2-microglobulin</article-title>
          <source>J. Biol. Chem.</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>47016</fpage>
          <lpage>47024</lpage>
          <pub-id pub-id-type="pmid">12958308</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>[21]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Platt</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>McParland</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Kalverda</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Homans</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Dynamics in the unfolded state of β2-microglobulin studied by NMR</article-title>
          <source>J. Mol. Biol.</source>
          <year>2005</year>
          <volume>346</volume>
          <fpage>279</fpage>
          <lpage>294</lpage>
          <pub-id pub-id-type="pmid">15663944</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>[22]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esposito</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The controlling roles of Trp60 and Trp95 in β2-microglobulin function, folding and amyloid aggregation properties</article-title>
          <source>J. Mol. Biol.</source>
          <year>2008</year>
          <volume>378</volume>
          <fpage>885</fpage>
          <lpage>895</lpage>
        </citation>
      </ref>
      <ref id="bib23">
        <label>[23]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xue</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Homans</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2008</year>
          <volume>105</volume>
          <fpage>8926</fpage>
          <lpage>8931</lpage>
          <pub-id pub-id-type="pmid">18579777</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>[24]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Ashcroft</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Direct observation of oligomeric species formed in the early stages of amyloid fibril formation using electrospray ionisation mass spectrometry</article-title>
          <source>J. Mol. Biol.</source>
          <year>2006</year>
          <volume>364</volume>
          <fpage>9</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">17005201</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <label>[25]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabian</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gast</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Laue</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Misselwitz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Uchanska-Ziegler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Naumann</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Early stages of misfolding and association of β2-microglobulin: insights from infrared spectroscopy and dynamic light scattering</article-title>
          <source>Biochemistry</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>6895</fpage>
          <lpage>6906</lpage>
          <pub-id pub-id-type="pmid">18540682</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>[26]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mamikonyan</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Anti-Aβ(1–11) antibody binds to different β-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers</article-title>
          <source>J. Biol. Chem.</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>22376</fpage>
          <lpage>22386</lpage>
          <pub-id pub-id-type="pmid">17545160</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>[27]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gazit</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>A possible role for π-stacking in the self-assembly of amyloid fibrils</article-title>
          <source>FASEB J.</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>77</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">11772939</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>[28]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ban</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence</article-title>
          <source>J. Biol. Chem.</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>16462</fpage>
          <lpage>16465</lpage>
          <pub-id pub-id-type="pmid">12646572</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>[29]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Morten</surname>
              <given-names>I.J.</given-names>
            </name>
            <name>
              <surname>Tennent</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Hewitt</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>A systematic study of the effect of physiological factors on β2-microglobulin amyloid formation at neutral pH</article-title>
          <source>Biochemistry</source>
          <year>2006</year>
          <volume>45</volume>
          <fpage>2311</fpage>
          <lpage>2321</lpage>
          <pub-id pub-id-type="pmid">16475820</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <label>[30]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Relini</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Collagen plays an active role in the aggregation of β2-microglobulin under physiopathological conditions of dialysis-related amyloidosis</article-title>
          <source>J. Biol. Chem.</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>16521</fpage>
          <lpage>16529</lpage>
          <pub-id pub-id-type="pmid">16601119</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>[31]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eakin</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Miranker</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>A native to amyloidogenic transition regulated by a backbone trigger</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>202</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">16491088</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>[32]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism by which the amyloid-like fibrils of a β2-microglobulin fragment are induced by fluorine-substituted alcohols</article-title>
          <source>J. Mol. Biol.</source>
          <year>2006</year>
          <volume>363</volume>
          <fpage>279</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="pmid">16959264</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <label>[33]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Tsutsumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kardos</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gejyo</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Low concentrations of sodium dodecyl sulfate induce the extension of β2-microglobulin-related amyloid fibrils at a neutral pH</article-title>
          <source>Biochemistry</source>
          <year>2004</year>
          <volume>43</volume>
          <fpage>11075</fpage>
          <lpage>11082</lpage>
          <pub-id pub-id-type="pmid">15323566</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <label>[34]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohhashi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kihara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Ultrasonication-induced amyloid fibril formation of β2-microglobulin</article-title>
          <source>J. Biol. Chem.</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>32843</fpage>
          <lpage>32848</lpage>
          <pub-id pub-id-type="pmid">16046408</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>[35]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sasahara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yagi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Amyloid nucleation triggered by agitation of β2-microglobulin under acidic and neutral pH conditions</article-title>
          <source>Biochemistry</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>2650</fpage>
          <lpage>2660</lpage>
          <pub-id pub-id-type="pmid">18211100</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <label>[36]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eichner</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>A generic mechanism of β2-microglobulin amyloid assembly at neutral pH involving a specific proline switch</article-title>
          <source>J. Mol. Biol.</source>
          <year>2009</year>
          <volume>386</volume>
          <fpage>1312</fpage>
          <lpage>1326</lpage>
          <pub-id pub-id-type="pmid">19452600</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>[37]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahn</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Homans</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Amyloid formation under physiological conditions proceeds via a native-like folding intermediate</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>195</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="pmid">16491092</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>[38]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ricagno</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>de Rosa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sangiovanni</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Giorgetti</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Raimondi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bellotti</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bolognesi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>DE loop mutations affect β2-microglobulin stability and amyloid aggregation</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2008</year>
          <volume>377</volume>
          <fpage>146</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">18835253</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>[39]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiti</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>A partially structured species of β2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis</article-title>
          <source>J. Biol. Chem.</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>46714</fpage>
          <lpage>46721</lpage>
          <pub-id pub-id-type="pmid">11590172</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>[40]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kameda</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hoshino</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Higurashi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Nuclear magnetic resonance characterization of the refolding intermediate of β2-microglobulin trapped by non-native prolyl peptide bond</article-title>
          <source>J. Mol. Biol.</source>
          <year>2005</year>
          <volume>348</volume>
          <fpage>383</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="pmid">15811375</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <label>[41]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>2754</fpage>
          <lpage>2759</lpage>
          <pub-id pub-id-type="pmid">11880627</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <label>[42]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahn</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Tennent</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>A common β-sheet architecture underlies in vitro and in vivo β2-microglobulin amyloid fibrils</article-title>
          <source>J. Biol. Chem.</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>17279</fpage>
          <lpage>17286</lpage>
          <pub-id pub-id-type="pmid">18424782</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <label>[43]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kihara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chatani</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Matsuura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Naiki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Conformation of amyloid fibrils of β2-microglobulin probed by tryptophan mutagenesis</article-title>
          <source>J. Biol. Chem.</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>31061</fpage>
          <lpage>31069</lpage>
          <pub-id pub-id-type="pmid">16901902</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <label>[44]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trinh</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Kalverda</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>S.E.V.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of monomeric human β2-microglobulin reveals clues to its amyloidogenic properties</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>9771</fpage>
          <lpage>9776</lpage>
          <pub-id pub-id-type="pmid">12119416</pub-id>
        </citation>
      </ref>
      <ref id="bib45">
        <label>[45]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>Role of the N and C-terminal strands of β2-microglobulin in amyloid formation at neutral pH</article-title>
          <source>J. Mol. Biol.</source>
          <year>2003</year>
          <volume>330</volume>
          <fpage>935</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="pmid">12860117</pub-id>
        </citation>
      </ref>
      <ref id="bib46">
        <label>[46]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid</surname>
              <given-names>F.X.</given-names>
            </name>
          </person-group>
          <article-title>Fast-folding and slow-folding forms of unfolded proteins</article-title>
          <source>Methods Enzymol.</source>
          <year>1986</year>
          <volume>131</volume>
          <fpage>70</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">3773774</pub-id>
        </citation>
      </ref>
      <ref id="bib47">
        <label>[47]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mimmi</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Variants of β2-microglobulin cleaved at lysine-58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature</article-title>
          <source>FEBS J.</source>
          <year>2006</year>
          <volume>273</volume>
          <fpage>2461</fpage>
          <lpage>2474</lpage>
          <pub-id pub-id-type="pmid">16704420</pub-id>
        </citation>
      </ref>
      <ref id="bib48">
        <label>[48]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corlin</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Johnsen</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Nissen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Heegaard</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>A β2-microglobulin cleavage variant fibrillates at near-physiological pH</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>2009</year>
          <volume>381</volume>
          <fpage>187</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">19232323</pub-id>
        </citation>
      </ref>
      <ref id="bib49">
        <label>[49]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Serpell</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Sunde</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Radford</surname>
              <given-names>S.E.</given-names>
            </name>
          </person-group>
          <article-title>A systematic investigation into the effect of protein destabilisation on β2-microglobulin amyloid formation</article-title>
          <source>J. Mol. Biol.</source>
          <year>2003</year>
          <volume>330</volume>
          <fpage>943</fpage>
          <lpage>954</lpage>
          <pub-id pub-id-type="pmid">12860118</pub-id>
        </citation>
      </ref>
      <ref id="bib50">
        <label>[50]</label>
        <citation citation-type="other">Jahn, T.R. (2006) Exploring the protein energy landscape for an amyloidogenic protein. Ph.D. Thesis, University of Leeds.</citation>
      </ref>
      <ref id="bib51">
        <label>[51]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Globular tetramers of β2 -microglobulin assemble into elaborate amyloid fibrils</article-title>
          <source>J. Mol. Biol.</source>
          <year>2009</year>
          <volume>389</volume>
          <fpage>48</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">19345691</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>(A) Schematic illustration of the competition between intra-molecular and inter-molecular interactions in protein folding and assembly. When intra-molecular interactions prevail, proteins fold or form collapsed states (left side). By contrast, when inter-molecular interactions dominate, protein aggregation results (right side). (B) Monomeric β<sub>2</sub>m with residues discussed herein highlighted. (C) Amyloid forming properties of the sequence of β<sub>2</sub>m when isolated as peptides <xref rid="bib10 bib11 bib12 bib13 bib14 bib15" ref-type="bibr">[10–15]</xref>, or in the context of the full-length protein (the latter at pH 2.5). Red circles indicate residues that affect fibril formation kinetics, blue circles indicate positions where changes had little or no effect on kinetics <xref rid="bib19" ref-type="bibr">[19]</xref>. (D) Structure of β<sub>2</sub>m (gold) in the MHC-1 complex. Hydrophobic residues present in the β-strand E region of β<sub>2</sub>m (Phe56, Trp60, Tyr62, Tyr63 and Leu65) that contact the heavy chain of the MHC-1 are highlighted.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Species formed en route to amyloid fibrils by β<sub>2</sub>m at pH 2.5 as monitored by mass spectrometry and ThT fluorescence. During the lag phase (blue line, bottom figure), the concentration of monomeric protein (red circles) decreases more rapidly than expected based on ThT data (grey line). ESI-MS data (top) shows the presence of dimers, trimers and tetramers as well as monomers, but no larger species, during the lag phase. At the conclusion of the reaction no oligomers remain. Data were taken from Smith et al. <xref rid="bib24" ref-type="bibr">[24]</xref>.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Structures of wild-type β<sub>2</sub>m and several variants mentioned herein, blue spheres show the site of mutation where relevant. Regions of major conformational change are highlighted. (A) WT β<sub>2</sub>m in the MHC-1 complex (PDB: 1DUZ) <xref rid="bib5" ref-type="bibr">[5]</xref>. (B) P32A variant of β<sub>2</sub>m that crystallises as a dimer and forms digomers in the presence of Cu<sup>2+</sup> (2F8O) <xref rid="bib31" ref-type="bibr">[31]</xref>. (C) Model of structural changes in a folding intermediate of β<sub>2</sub>m, populated at high levels in the P32G variant, mapped onto the NMR structure of wild-type β<sub>2</sub>m. Regions that are most perturbed in comparison with wild-type β<sub>2</sub>m are shown in red, those that show little perturbation are pink and no information is available for those in grey <xref rid="bib37" ref-type="bibr">[37]</xref>. (D) X-ray crystallographic structure of a rare monomeric species of wild-type β<sub>2</sub>m with a straight β-strand D (1LDS) <xref rid="bib44" ref-type="bibr">[44]</xref>. (E) W60G variant of β<sub>2</sub>m that has a decreased amyloid propensity (2Z9T) <xref rid="bib22" ref-type="bibr">[22]</xref>. (F) D59P β<sub>2</sub>m displays an increased propensity to form amyloid (3DHJ) <xref rid="bib38" ref-type="bibr">[38]</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>(A) Comparison of experimental data for fibrils of β<sub>2</sub>m formed at pH 7.0 and 2.5. EM scale bar indicates 100 nm. Absorbance spectra of Congo Red free in solution (black line) and bound to β<sub>2</sub>m fibrils (red line) as well as the difference spectra (inset). Both fibril types give rise to red-green birefringence in the presence of Congo Red. The X-ray fibre diffraction patterns show reflections at 4.7 Å and ∼10 Å, consistent with a cross-β structure. Data were taken from Jahn <xref rid="bib50" ref-type="bibr">[50]</xref>. (B) Scheme for convergence of the mechanisms of fibril formation at pH 2.5 and 7.0. Regions with high amyloidogenic propensity are displayed in pink. It is not known precisely how oligomers stack or whether they have ordered β-sheet, however, increased intermolecular protein–protein interactions (red) may be important in the reaction pathway.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-wrap>
</article>